Last year’s UK biotech financing dip extends into 2023

The first quarter of 2023 saw just £295 million raised by UK-based life sciences and biotech companies, signalling that investor confidence remains low after a disappointi

UK biotech sees worst funding downturn since 2012

The UK BioIndustry Association (BIA) and data and insights company Clarivate have released their annual UK Biotech Financing report

Blockbusters in waiting: Clarivate's drugs to watch in 2023

New drugs for immunological and inflammatory diseases feature prominently among new product launches this year that could top $1 billion in annual sales by 2027 or be clinical "game changer

Offshore warning as UK biotech investment rises sharply in 2...

2021 was a record year for investments in UK biotech companies, consolidating the country's position as one of Europe's top life science hubs and apparently shrugging off the effects of the

UK biotech 'booming' as sector rakes in £1.6bn in Q2 financi...

The UK's biotechnology sector is going through a purple patch, attracting almost £1.6 billion ($2.2 billion) in financing in the three months to end-May – which is a record for the industry

Blockbusters in waiting: drug launches to watch in 2020